BlackRock Capital Allocation Term Trust (BCAT) Competitors $14.80 +0.25 (+1.68%) Closing price 08/22/2025 03:58 PM EasternExtended Trading$14.87 +0.06 (+0.44%) As of 08/22/2025 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCAT vs. DNP, ADX, PTY, GAB, RVT, NUV, STEW, OXLC, CET, and GSBDShould you be buying BlackRock Capital Allocation Term Trust stock or one of its competitors? The main competitors of BlackRock Capital Allocation Term Trust include DNP Select Income Fund (DNP), Adams Diversified Equity Fund (ADX), Pimco Corporate & Income Opportunity Fund (PTY), Gabelli Equity Trust (GAB), Royce Small-Cap Trust (RVT), Nuveen Municipal Value Fund (NUV), SRH Total Return Fund (STEW), Oxford Lane Capital (OXLC), Central Securities (CET), and Goldman Sachs BDC (GSBD). These companies are all part of the "financial services" industry. BlackRock Capital Allocation Term Trust vs. Its Competitors DNP Select Income Fund Adams Diversified Equity Fund Pimco Corporate & Income Opportunity Fund Gabelli Equity Trust Royce Small-Cap Trust Nuveen Municipal Value Fund SRH Total Return Fund Oxford Lane Capital Central Securities Goldman Sachs BDC DNP Select Income Fund (NYSE:DNP) and BlackRock Capital Allocation Term Trust (NYSE:BCAT) are both financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation. Do insiders and institutionals believe in DNP or BCAT? 8.5% of DNP Select Income Fund shares are held by institutional investors. Comparatively, 36.1% of BlackRock Capital Allocation Term Trust shares are held by institutional investors. 0.1% of DNP Select Income Fund shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer DNP or BCAT? In the previous week, BlackRock Capital Allocation Term Trust had 3 more articles in the media than DNP Select Income Fund. MarketBeat recorded 3 mentions for BlackRock Capital Allocation Term Trust and 0 mentions for DNP Select Income Fund. BlackRock Capital Allocation Term Trust's average media sentiment score of 1.90 beat DNP Select Income Fund's score of 0.00 indicating that BlackRock Capital Allocation Term Trust is being referred to more favorably in the news media. Company Overall Sentiment DNP Select Income Fund Neutral BlackRock Capital Allocation Term Trust Very Positive Is DNP or BCAT a better dividend stock? DNP Select Income Fund pays an annual dividend of $0.78 per share and has a dividend yield of 7.9%. BlackRock Capital Allocation Term Trust pays an annual dividend of $3.40 per share and has a dividend yield of 23.0%. Is DNP or BCAT more profitable? Company Net Margins Return on Equity Return on Assets DNP Select Income FundN/A N/A N/A BlackRock Capital Allocation Term Trust N/A N/A N/A Which has better earnings & valuation, DNP or BCAT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDNP Select Income FundN/AN/AN/AN/AN/ABlackRock Capital Allocation Term Trust$197.67M8.05N/AN/AN/A Which has more volatility and risk, DNP or BCAT? DNP Select Income Fund has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, BlackRock Capital Allocation Term Trust has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. SummaryBlackRock Capital Allocation Term Trust beats DNP Select Income Fund on 6 of the 7 factors compared between the two stocks. Get BlackRock Capital Allocation Term Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCAT vs. The Competition Export to ExcelMetricBlackRock Capital Allocation Term TrustElectronic Computer Manufacturing IndustryManufacturing SectorNYSE ExchangeMarket Cap$1.59B$2.55B$2.59B$20.92BDividend Yield22.92%2.51%2.55%3.58%P/E RatioN/A28.8822.0129.13Price / Sales8.055.1682.7353.00Price / CashN/AN/A23.4723.54Price / BookN/AN/A31.915.45Net IncomeN/A-$19.32M$31.01M$992.10M7 Day Performance-0.57%0.84%1.04%2.61%1 Month Performance-1.14%1.11%1.14%1.46%1 Year Performance-9.78%9.13%29.20%10.72% BlackRock Capital Allocation Term Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCATBlackRock Capital Allocation Term TrustN/A$14.81+1.7%N/A-9.4%$1.59B$197.67M0.00147,000DNPDNP Select Income FundN/A$9.83+0.1%N/A+6.7%$3.63BN/A0.00590ADXAdams Diversified Equity FundN/A$21.84-0.6%N/A+2.7%$2.58BN/A0.0030News CoveragePositive NewsPTYPimco Corporate & Income Opportunity FundN/A$13.98+0.2%N/A-1.0%$2.53BN/A0.00147,000GABGabelli Equity TrustN/A$5.98+0.3%N/A+11.2%$1.83BN/A0.00N/ANews CoveragePositive NewsDividend AnnouncementRVTRoyce Small-Cap TrustN/A$15.60+0.4%N/A+5.3%$1.79BN/A0.0050Positive NewsNUVNuveen Municipal Value FundN/A$8.60-0.1%N/A-2.1%$1.78BN/A0.00640Positive NewsSTEWSRH Total Return FundN/A$17.98+0.1%N/A+18.4%$1.73BN/A0.00N/ANews CoverageDividend AnnouncementOXLCOxford Lane Capital2.2185 of 5 stars$3.42flatN/A-32.4%$1.55B$57.31M4.12601Positive NewsCETCentral SecuritiesN/A$49.64-0.3%N/A+13.1%$1.44B$222.17M0.006News CoveragePositive NewsGSBDGoldman Sachs BDC1.5336 of 5 stars$11.15+0.2%$10.00-10.3%-19.0%$1.27B$434.37M8.85N/ANews CoveragePositive NewsDividend Cut Related Companies and Tools Related Companies DNP Competitors ADX Competitors PTY Competitors GAB Competitors RVT Competitors NUV Competitors STEW Competitors OXLC Competitors CET Competitors GSBD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BCAT) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BlackRock Capital Allocation Term Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share BlackRock Capital Allocation Term Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access